Skip to search formSkip to main contentSkip to account menu

ombitasvir / paritaprevir / Ritonavir

Known as: OBV/PTV/r, OMBITASVIR/PARITAPREVIR/RITONAVIR, ombitasvir, paritaprevir and ritonavir 
An orally bioavailable combination agent containing ombitasvir, an inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A… 
National Institutes of Health

Related topics

Related topics

3 relations
Ritonavirombitasvirparitaprevir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions
AIM To quantify drug-drug-interactions (DDIs) encountered in patients prescribed hepatitis C virus (HCV) treatment, the… 
2017
2017
Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration
Data addressing real world effectiveness of direct acting antiviral agents in hepatitis C infected patients are now emerging… 
2017
2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir
Background Ombitasvir/paritaprevir/ritonavir with dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV) is approved for hepatitis C virus… 
2016
2016
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US
Abstract Objective: This study compared the cost-effectiveness of direct-acting antiviral therapies currently recommended for… 
2016
2016
Drug–Drug Interaction of Omeprazole With the HCV Direct‐Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir
Paritaprevir (administered with low‐dose ritonavir), ombitasvir, and dasabuvir are direct‐acting antiviral agents administered as… 
2016
2016
Real-World Safety and Effectiveness of Ombitasvir/ Paritaprevir/R with Dasabuvir and/or Ribavirin in the German Hepatitis C Registry
Review
2015
Review
2015
Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients.
The goal of therapy in chronic hepatitis C virus (HCV) infection is sustained virological response (SVR) which reflects HCV… 
2006
2006
Singlet-triplet splittings and their relevance to the spin-dependent exciton formation in light-emitting polymers: an EOM/CCSD study.
By employing the coupled-cluster equation of motion method (EOM/CCSD) for excited-state structures, we have investigated the… 
2005
2005
2-Step IMAT and 2-Step IMRT in three dimensions.
In two dimensions, 2-Step Intensity Modulated Arc Therapy (2-Step IMAT) and 2-Step Intensity Modulated Radiation Therapy (IMRT… 
2004
2004
The Incidence of Inclusion of the Sigmoid Colon and Small Bowel in the Planning Target Volume in Radiotherapy for Prostate Cancer
Background and Purpose:In radiotherapy for prostate cancer, the rectum is considered the dose-limiting organ. The incidence of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)